or Try an Advanced Search...

    Technical Analysis for ADAG - Adagene Inc.

    Grade Last Price % Change Price Change
    F 2.09 -5.86% -0.13
    ADAG closed down 5.86 percent on Wednesday, November 20, 2024, on 31 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ADAG trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    180 Bearish Setup Bearish Swing Setup -5.86%
    NR7 Range Contraction -5.86%
    Lower Bollinger Band Walk Weakness -5.86%
    Wide Bands Range Expansion -5.86%
    Gapped Up Strength -5.86%
    Oversold Stochastic Weakness -5.86%
    Lizard Bullish Bullish Day Trade Setup -6.70%
    Older End-of-Day Signals for ADAG ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 17 hours ago
    Up 5% about 17 hours ago
    Up 3% about 17 hours ago
    Bearish 180 Entry about 17 hours ago
    Fell Below Previous Day's Low about 17 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    ADAG Chart by TradingView
    Basic chart:

    Profile

    Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Artificial Intelligence Immunology Immunotherapy Antibodies Health Care Cancer Immunotherapy Virotherapy Antibody Immunotherapies

    Is ADAG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 21 Adagene And 2 Other US Penny Stocks To Consider
    Oct 9 Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
    Sep 27 Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?
    Sep 16 Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
    Sep 16 Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
    Sep 11 Are Medical Stocks Lagging Adagene (ADAG) This Year?
    Aug 29 Adagene to Participate in Investor Conferences in September
    Aug 26 Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
    Aug 9 Is MannKind (MNKD) Stock Outpacing Its Medical Peers This Year?
    Jul 28 Adagene First Half 2024 Earnings: US$0.39 loss per share (vs US$0.094 loss in 1H 2023)
    See more ADAG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.38
    52 Week Low 1.36
    Average Volume 70,749
    200-Day Moving Average 2.71
    50-Day Moving Average 2.52
    20-Day Moving Average 2.71
    10-Day Moving Average 2.40
    Average True Range 0.30
    RSI (14) 33.33
    ADX 30.07
    +DI 9.47
    -DI 27.29
    Chandelier Exit (Long, 3 ATRs) 2.26
    Chandelier Exit (Short, 3 ATRs) 2.90
    Upper Bollinger Bands 3.45
    Lower Bollinger Band 1.97
    Percent B (%b) 0.08
    BandWidth 54.82
    MACD Line -0.12
    MACD Signal Line -0.03
    MACD Histogram -0.0955
    Fundamentals Value
    Market Cap 91.61 Million
    Num Shares 43.8 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -2.43
    Price-to-Sales 6.89
    Price-to-Book 1.85
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.50
    Resistance 3 (R3) 2.54 2.45 2.43
    Resistance 2 (R2) 2.45 2.35 2.43 2.40
    Resistance 1 (R1) 2.27 2.28 2.23 2.23 2.38
    Pivot Point 2.18 2.18 2.16 2.16 2.18
    Support 1 (S1) 2.00 2.08 1.96 1.96 1.80
    Support 2 (S2) 1.91 2.01 1.89 1.78
    Support 3 (S3) 1.73 1.91 1.75
    Support 4 (S4) 1.69